Tanzania

Section divider

Since 1999, our focus has been on quality health services for families.

  • More than 4.4 million Tanzanians have learned their HIV status through Jhpiego-led initiatives and more than 1 million men have received voluntary medical male circumcision services for HIV prevention.
  • Over 41,000 women have been screened for cervical cancer, with 98% of the 2,384 women identified as having precancerous lesions and eligible for cryotherapy treated.
  • More than 2.4 million antenatal care visits and more than 773,000 deliveries took place at Jhpiego-supported health care facilities.
  • More than 10,000 health care providers in over 1,800 facilities countrywide have the skills to competently provide high-quality antenatal care and basic emergency obstetric and newborn care to pregnant women.

Our Work in Tanzania

This project is funded by Global Affairs Canada to make significant contributions to ensuring that women and children in the Lake and Western Zones of Tanzania have greater access to skilled midwifery care. Jhpiego and its partners, Amref Health Africa in Tanzania and the Canadian Association of Midwives, are supporting the Tanzanian Ministry of Health, Community Development, Gender, Elderly and Children to fulfill national priorities for maternal and newborn survival. They are also addressing inadequate numbers and inequitable distribution of human resources for health for midwifery care. Project beneficiaries include nursing-midwifery students, tutors, trainers and preceptors who provide education and training, as well as practicing nurse-midwives who participate in in-service training and/or receive onsite mentoring in the Lake and Western Zones.

Led by Jhpiego and funded by the U.S. Agency for International Development and U.S. President’s Malaria Initiative, the USAID Boresha Afya project is working to improve the health status of all Tanzanians—with an emphasis on women and children in targeted regions—by improving the availability of, and access to, high-quality, respectful and integrated health services. The project focuses on reproductive, maternal, newborn and child health outcomes and is taking place in a total of 1,823 health facilities in selected districts of Zanzibar and seven regions of the Lake and Western Zones (Geita, Kagera, Kigoma, Mara, Mwanza, Simiyu and Shinyanga).

RISE is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). RISE works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems by 2024. RISE’s contributions to this work will lead to fewer new HIV infections, decreased HIV-related morbidity and mortality, and increased quality of life for people living with HIV. With USAID PEPFAR investments, RISE supports countries to achieve and maintain epidemic control by providing strategic technical assistance and direct service delivery to improve HIV prevention, case finding, treatment programming, and viral load suppression. The primary objectives of the RISE project are to: 1) attain and maintain HIV epidemic control among at-risk adult men, women and priority populations; 2) attain and maintain HIV epidemic control among key populations; 3) strengthen health systems including improved program management, health information systems, human resources for health and financial systems to ensure attainment and maintenance of epidemic control; and 4) support the transition of direct funding and implementation to capable local partners to meet the PEPFAR goal of 70% of funding to local partners by 2020. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights, and Mann Global Health. RISE is currently active in several countries, including Tanzania.

The Challenge Initiative (TCI), which is funded by the Bill & Melinda Gates Institute for Population and Reproductive Health, focuses on scaling up the success in increasing family planning (FP) access under the Tupange Urban Reproductive Health Initiative. TCI aims to assist Kenya, Uganda and Tanzania to scale up FP services to reach additional women and girls over the next three to five years. TCI is breaking ground in developing a technical assistance model that incentivizes governments and local and global donors to buy into the most successful and high-impact FP interventions, rapidly adapt these interventions to the local context and support counties and districts to efficiently scale them up through targeted technical assistance. In Tanzania, the project covers all of the country’s major cities (Arusha, Dar es Salaam, Mwanza, Mbeya and Tanga). For more information, visit here: https://tciurbanhealth.org.

Led by the Medical College of Cornell University and funded by the Bill & Melinda Gates Foundation, Jhpiego is leading the Tanzania-based portion of a research study evaluating the ShangRing vs. Mogen Clamp for early infant male circumcision (EIMC) in sub-Saharan Africa. This study aims to: 1) compare the safety and acceptability of the ShangRing for EIMC in neonates and infants up to 60 days old with the existing Mogen clamp; 2) assess whether device-driven EIMC can be safely and effectively integrated with pre-existing maternal and child health services as a means to foster male circumcision demand creation; and 3) assess the cost impact of EIMC using the two different technologies.

This three-year project, funded by the Bill & Melinda Gates Foundation, seeks to uphold the quality of contraceptive implant services by working at the global and country levels. Globally, Jhpiego serves in a technical advisory role for the Implant Access Program’s Operations Group—a working group comprised of donor representatives that supports quality implant programs—to monitor, identify and collaboratively respond to priority issues. Jhpiego also provides short-term technical assistance to ensure that several countries with high implant use, including Tanzania, incorporate a quality implant removal component into overall implant strategy and implementation.

With funding from Gavi, the Vaccine Alliance—and in conjunction with the Tanzanian Ministry of Health, Community Development, Gender, Elderly and Children—Jhpiego is collaborating with a consortium of partners to introduce the human papillomavirus (HPV) vaccine and achieve 80% coverage nationwide. Jhpiego supports this goal by: increasing the capacity of health care workers in target regions to provide HPV vaccination to adolescent girls; supporting the design and execution of effective and innovative advocacy, communication and social mobilization strategies; supporting the development of effective service delivery and engagement strategies to achieve high-quality services and high coverage of HPV vaccination in Iringa Region; and provide global leadership on HPV vaccination and share lessons learned at national and global scales.